Basmajian v. Cohen

District Court, E.D. California·Decided December 21, 2023·No. 1:23-cv-00063·Unknown

Opinion

TINA BASMAJIAN and DAVID No. 1:23-cv-00063-TLN-AC BASMAJIAN, Plaintiffs, v. UNITED STATES; and DOES 1 to 100 Defendants.

This matter is before the Court on Defendant United States’1 (“Defendant”) Motion for Summary Judgment. (ECF No. 14.) Plaintiffs Tina Basmajian (“Mrs. Basmajian”) and David Basmajian (“Mr. Basmajian”) (collectively, “Plaintiffs”) filed an opposition.2 (ECF No. 19.) Defendant filed a reply. (ECF No. 21.) For the reasons set forth below, the Court GRANTS in

1 On July 28, 2023, Defendant filed a Notice of Substitution of Parties, substituting the United States as defendant in place of Edward Cohen, M.D., Michelle Solone M.D., and the Veterans Administration. (ECF No. 13). 2 Plaintiffs untimely filed their opposition. See E.D. Cal. L.R. 230(c) (“Opposition, if any, to the granting of the motion shall be in writing and shall be filed and served no later than fourteen (14) days after the motion was filed.”). However, the Court, in its discretion, will consider the filing. part and DENIES in part Defendant’s motion. I. FACTUAL AND PROCEDURAL BACKGROUND3 From 2008 until approximately 2022, Mrs. Basmajian received medical care from the United States Department of Veterans Affairs (the “VA”) in Palo Alto, California. (ECF No. 21- 1 at 1.) Mrs. Basmajian has a BRCA1 gene mutation and as a result is at a higher risk of developing certain types of cancers. (ECF No. 1 at 4.) From 2008 to 2017, Dr. Edward Cohen, M.D. (“Dr. Cohen”) treated and performed regular pap smears on Mrs. Basmajian to screen her for cancer and other diseases. (Id.) In February 2017, Mrs. Basmajian was informed Dr. Cohen had retired and she would be assigned another VA doctor. (Id.) She was eventually assigned to Dr. Michelle Solone, M.D. (“Dr. Solone”), after over a year of trying to secure care from a VA doctor. (Id. at 5.) Mrs. Basmajian had her first appointment with Dr. Solone on October 4, 2018. (Id.) On December 5, 2018, Mrs. Basmajian had her annual pap smear and received her results on December 21, 2018. (Id.) The results from this pap smear indicated Mrs. Basmajian was HPV positive. (Id.) Dr. Solone then recommended Mrs. Basmajian undergo a colposcopy4, which was scheduled for February 15, 2019. (Id. at 2.) After receiving concerning colposcopy results, Mrs. Basmajian underwent an LEEP invasive biopsy on March 12, 2019. (Id.) The biopsy results indicated Mrs. Basmajian had cervical cancer. (Id.) To treat her cancer, Mrs. Basmajian received a total hysterectomy and lymph node dissection on May 7, 2019. (ECF No. 1 at 6.) Mrs. Basmajian experienced complications from her total hysterectomy and as a result underwent four additional follow-up surgeries, including two mesh repairs, a drain replacement, and an infected drain surgery. (Id.) /// /// 3 The following facts are undisputed unless otherwise indicated.

4 “Colposcopy (kol-POS-kuh-pee) is a procedure to closely examine your cervix, vagina and vulva for signs of disease.” https://www.mayoclinic.org/tests-procedures/colposcopy/about/pac-20385036 (last visited Oct. 18, 2023). On March 25, 2020, Mrs. Basmajian received a letter, dated March 23, 2020 (“March 23 Letter”), written by Dr. Lawrence Leung, M.D.5 (ECF No. 21-1 at 3.) The letter stated a peer review committee determined Mrs. Basmajian’s cancer diagnosis could have been made three months to a year sooner if the colposcopy procedure had been performed in October of 2017 or 2018. (Id.) The March 23 Letter informed Mrs. Basmajian of her right to file a Federal Tort Claims Act (“FTCA”) claim against the VA and her doctors. (ECF No. 21-1 at 4.) Mrs. Basmajian decided to file an FTCA claim, and Plaintiffs allege Mrs. Basmajian then sent her FTCA claim to the VA using Standard Form 95 (“SF 95”) on March 15, 2022. (Id.) The VA contends it received Mrs. Basmajian’s administrative claim on April 7, 2022.6 (Id. at 2.) On July 22, 2022, the VA denied Mrs. Basmajian’s claim. (Id. at 4.) On January 13, 2023, Plaintiffs filed the operative Complaint, alleging two causes of action: (1) Mrs. Basmajian’s claim for medical malpractice and professional negligence; and (2) Mr. Basmajian’s claim for loss of consortium. (ECF No. 1 at 7, 9.) On July 28, 2023, Defendant filed the instant motion for summary judgment. (ECF No. 14.) Summary judgment is appropriate when the moving party demonstrates no genuine issue of any material fact exists and the moving party is entitled to judgment as a matter of law. Fed. R. Civ. P. 56(a); Adickes v. S.H. Kress & Co., 398 U.S. 144, 157 (1970). Under summary judgment practice, the moving party always bears the initial responsibility of informing the district court of the basis of its motion, and identifying those portions of “the pleadings, depositions, answers to interrogatories, and admissions on file together with affidavits, if any,” which it believes demonstrate the absence of a genuine issue of material fact. Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986). “[W]here the nonmoving party will bear the burden of proof at trial on a dispositive issue, a summary judgment motion may properly be made in reliance

Free access — add to your briefcase to read the full text and ask questions with AI

Basmajian v. Cohen, (E.D. Cal. 2023).

Basmajian v. Cohen (Basmajian v. Cohen) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related